MedMyne Announces Rebrand to Thynk Health

  LEXINGTON, KY - 12/13/2018 (PRESS RELEASE JET)

New brand reinforces an investment in innovating healthcare technology and serves as an opportunity to remain unique in the marketplace.

MedMyne, a complete cancer screening platform, announces the company’s rebrand to Thynk Health. The rebrand elevates the focus on the use of advanced technologies including artificial intelligence and natural language processing to optimize data-driven workflows for cancer screening programs.

Thynk Health is a software-as-a-service platform that automates manual processes including data abstraction, data entry, patient communication, and ACR Lung Cancer Screening Registry submissions, allowing healthcare professionals to focus on improving patient care navigation and treatment outcomes.

“Our mission is to make cancer screening more powerful, efficient, and effective. The rebrand to Thynk Health will increase awareness in the healthcare technology industry of our innovative use of artificial intelligence and natural language processing,” said Jeffrey Markowitz, CEO of Thynk Health.

The rebrand comes at the same time as the completion of a capital raise from a group of private investors including the Kentucky Bluegrass Angels. Concurrent with the raise the company was awarded a $250,000 jobs grant from the Lexington Fayette Urban County Government. The additional capital will allow Thynk Health to continue expansion of our cancer screening platform, automation of manual data workflow processes for numerous quality initiatives, and the addition of more end-user features to the Thynk Health solution.

Please visit ThynkHealth.com to explore the new website, brand and learn more about the solutions offered by Thynk Health’s Complete Lung Cancer Screening Platform.

About Thynk Health

The Thynk Health platform optimizes data-driven workflows and provides operational and clinical analytics for lung cancer screening programs and other quality initiatives. Learn more at www.thynkhealth.com.